Inventor · disambiguated record
Andreas Clemens
Also filed as: CLEMENS ANDREAS · CLEMENS ANDREAS HÄFELE
1 granted patent·12 pending applications·0 citations·filing 2007–2021
9Inventor score
Top patents by PatentIndex Score
13 records- 0154US11051917B2Prosthesis as well as retrofit kit for a prosthesisIVOCLAR VIVADENT AG·Filed 2019·Granted Jul 6, 2021·0 cites·15 claims
- 0248US2023416351A1Vegf antagonist for use in methods for treating ocular diseasesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0348US2011306640A1Dabigatran in tumour therapyVAN RYN JOANNE·Filed 2009·Application pending·0 cites
- 0447US2008039391A1New Indications for Direct Thrombin Inhibitors in the Cardiovascular FieldBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 0546US2020113662A1Method of Manufacturing A Dental Restoration PartIVOCLAR VIVADENT AG·Filed 2019·Application pending·0 cites
- 0645US2014051728A1Dabigatran in tumor therapyVAN RYN JOANNE·Filed 2013·Application pending·0 cites
- 0745US2008200514A1Indications for Direct Thrombin InhibitorsBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 0841US2013345262A1Method for prevention of strokeDUGI KLAUS·Filed 2013·Application pending·0 cites
- 0938US2013302311A1Emergency interventions of active charcoal with dabigatran etexilate overdosingVAN RYN JOANNE·Filed 2013·Application pending·0 cites
- 1036US2008015176A1New Paediatric Indications for Direct Thrombin InhibitorsBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 1133US2010173947A1New Indications for Direct Thrombin InhibitorsBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 1233US2011206656A1Emergency interventions of active charcoal with dabigatran etexilate overdosingBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 1326US2011015129A1New paediatric indications for direct thrombin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Clemens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →